IMMF: An Interpretable Multi-Modal Framework for Hypothesis-Driven Biomarker Discovery in Triple-Negative Breast Cancer Using Public Data
Triple-Negative Breast Cancer (TNBC) is characterized by high heterogeneity, poor prognosis, and limited targeted treatment options. Bridging the gap between molecular alterations and histopathological morphology remains a major challenge in precision oncology. We propose an interpretable, multi-modal framework that integrates histopathological image analysis with multi-omics profiling (somatic mutations, DNA methylation, copy number alterations), leveraging U-Net-based nuclei segmentation, vision-language models (BLIP), biomedical language models (BioGPT), and explainable AI (SHAP, LIME). Our framework achieves strong predictive performance (AUC = 0.989) and provides transparent, biologically grounded interpretations by integrating morphological features with genomically prioritized biomarkers. Cross-modal analysis confirms established TNBC drivers and generates novel, testable hypotheses associating specific epigenetic alterations with distinct morphological phenotypes. While causal validation requires future wet-lab experiments, our framework accelerates hypothesis-driven biomarker discovery by integrating complementary data modalities with language-based reasoning, providing a transparent foundation for hypothesis generation and clinical translation.